AVEO PHARMACEUTICALS INC's ticker is AVEO and the CUSIP is 053588109.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $331,000 | -87.9% | 100,000 | -89.4% | 0.00% | -90.9% |
| Q1 2018 | $2,727,000 | +225.8% | 940,403 | +213.5% | 0.01% | +175.0% |
| Q4 2017 | $837,000 | -23.6% | 300,000 | -0.1% | 0.00% | -20.0% |
| Q3 2017 | $1,096,000 | -83.5% | 300,300 | -90.0% | 0.01% | -86.5% |
| Q2 2017 | $6,660,000 | – | 3,000,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Greylock XI GP Limited Partnership | 584,004 | $1,068,000 | 100.00% |
| GREAT POINT PARTNERS LLC | 2,325,000 | $4,255,000 | 1.89% |
| Sarissa Capital Management LP | 2,570,759 | $4,704,000 | 1.60% |
| Deer VI & Co. LLC | 675,242 | $1,236,000 | 0.68% |
| Palo Alto Investors LP | 1,200,800 | $2,197,000 | 0.16% |
| Baupost Group | 3,829,350 | $7,008,000 | 0.11% |
| Gruss Capital Management LP | 533,253 | $976,000 | 0.05% |
| Granahan Investment Management | 676,451 | $1,238,000 | 0.04% |
| Fore Research & Management, LP | 674,200 | $1,233,000 | 0.04% |
| TFS CAPITAL LLC | 210,369 | $385,000 | 0.03% |